Zura Bio (ZURA) Income towards Parent Company (2022 - 2026)

Zura Bio's Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$24.2 million for Q1 2026.

• On a quarterly basis, Income towards Parent Company fell 38.88% year-over-year to -$24.2 million in Q1 2026; TTM through Mar 2026 was -$76.4 million, a 277.06% decrease from a year earlier, with the FY2025 full-year figure at -$55.2 million, down 412.24% from the prior year.
• Income towards Parent Company slipped to -$24.2 million in Q1 2026 per ZURA's latest filing, from -$18.1 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $28.2 million in Q4 2024 and bottomed at -$34.0 million in Q2 2023.
• The 5-year median for Income towards Parent Company is -$9.8 million (2023), against an average of -$10.4 million.
• Across the five-year window, Income towards Parent Company plunged 3578.38% in 2023 and jumped 432.96% in 2024, its largest moves.
• Year by year, Income towards Parent Company stood at -$2.2 million in 2022, then sank by 279.27% to -$8.5 million in 2023, then soared by 432.96% to $28.2 million in 2024, then tumbled by 164.3% to -$18.1 million in 2025, then slumped by 33.53% to -$24.2 million in 2026.
• Per Business Quant, the three latest ZURA Income towards Parent Company figures stand at -$24.2 million (Q1 2026), -$18.1 million (Q4 2025), and -$18.0 million (Q3 2025).